| scholarly article | Q13442814 |
| P50 | author | Alberto Brolese | Q73093330 |
| Patrizia Burra | Q56336126 | ||
| P2093 | author name string | Guido M | |
| Fagiuoli S | |||
| Pevere S | |||
| Masier A | |||
| Germani G | |||
| Canova D | |||
| Tomat S | |||
| Targhetta S | |||
| Boninsegna S | |||
| D'Aloiso C | |||
| P2860 | cites work | Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation | Q73398706 |
| Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients | Q74296454 | ||
| Hepatitis C and liver transplantation | Q77110599 | ||
| Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence | Q27477988 | ||
| A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients | Q28346817 | ||
| Histological grading and staging of chronic hepatitis | Q29619625 | ||
| Recurrent hepatitis C after liver transplantation | Q33969819 | ||
| Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: influence of immunosuppressive regimens | Q34468871 | ||
| Hepatitis C after orthotopic liver transplantation | Q41345035 | ||
| The association between hepatitis C infection and survival after orthotopic liver transplantation | Q42672810 | ||
| Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase cha | Q42984595 | ||
| Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection | Q42985135 | ||
| Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. | Q42988520 | ||
| Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin | Q42989795 | ||
| Predictors of patient and graft survival following liver transplantation for hepatitis C. | Q42989860 | ||
| High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. | Q42991412 | ||
| Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation | Q43000722 | ||
| Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver | Q43036220 | ||
| Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. | Q43040909 | ||
| Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. | Q43049480 | ||
| The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis | Q43705830 | ||
| A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. | Q44190776 | ||
| Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury | Q44213614 | ||
| Outcome of orthotopic liver transplantation in patients with hepatitis C. | Q45713243 | ||
| Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft | Q45734092 | ||
| Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation | Q45740469 | ||
| Human leukocyte interferon-alpha treatment for chronic HCV-related hepatitis in hemophilic patients previously intolerant to other interferons-alpha | Q45883548 | ||
| Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination | Q47926027 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| liver transplantation | Q1368191 | ||
| P304 | page(s) | 1127-1130 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Transplantation Proceedings | Q7834825 |
| P1476 | title | Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience | |
| P478 | volume | 38 |
| Q50574871 | Antiviral therapy for hepatitis C in the setting of liver transplantation. |
| Q35161778 | Effect of ribavirin alone or combined with silymarin on carbon tetrachloride induced hepatic damage in rats |
| Q50563949 | Efficacy of interferon Beta combined with cyclosporine induction and intensified therapy for retreatment of chronic hepatitis C. |
| Q62804139 | Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical outcome |
| Q44974539 | HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma |
| Q43195974 | Hepatoprotective effects of the nitric oxide donor isosorbide-5-mononitrate alone and in combination with the natural hepatoprotectant, silymarin, on carbon tetrachloride-induced hepatic injury in rats. |
| Q36788362 | Management of hepatitis C infection after liver transplantation |
| Q36758660 | Therapeutic management of recurrent hepatitis C after liver transplantation |
| Q50567515 | [The prophylaxis and treatment of c virus liver disease in the liver transplantation setting. Narrative review] |
Search more.